Measuring muscle relaxant duration in infants during skull surgery
Treatments studied
This trial tests how long a muscle relaxant (rocuronium) works in infants aged 3-12 months having skull surgery for a condition called craniosynostosis. The results may help doctors give safer and more effective doses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is between 3 and 12 months old
- Your baby will have surgery to treat craniosynostosis (a condition where skull bones fuse too early)
- You have given written permission for your baby to join this study
- Your baby does not have muscle or nerve diseases, or severe liver or kidney problems
- Your baby is not allergic to any of the medicines used in the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if different levels of muscle relaxation during abdominal surgery affect lung function and breathing problems after surgery. It may help patients who are having open abdominal surgery under general anesthesia lasting over an hour.
This study tests how well a medication can reverse the effects of a muscle relaxant used during anesthesia. The goal is to help your muscles work normally again after surgery so you wake up safely.
This study tests a new way to check how well muscle relaxants are working in intensive care patients. It aims to make sure the monitoring is reliable, which could help doctors adjust treatment better for each patient.
This trial tests two different medicines used to reverse muscle relaxation after lung surgery. It looks at which one helps you breathe better in the first hours after your procedure.
This study looks at how muscle relaxants affect the size of your upper airway. It aims to help doctors understand how to safely reverse these medications after surgery.
This study tests two devices that measure how well muscle relaxants work in young children during surgery. The goal is to see which device gives more accurate readings, helping doctors use the right dose of relaxant.
Hear when a new Neuromuscular Blocking Agents trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.